China Pioneer Pharma Holdings Limited provided earnings guidance for the year ended December 31, 2015. The board of directors of the Company inform's the shareholders of the Company and potential investors that, based on the preliminary review on the management accounts of the Group for the year ended December 31, 2015 and the information currently available to the Board, the Group is expected to record a decrease in profit for Year 2015 as compared with that reported for the year ended December 31, 2014. Such decrease in profit for Year 2015 was mainly attributable to: the operation loss of the overseas associates of the Company for Year 2015; the substantial decrease of the sales of WaveLight Eagle laser surgical series, one of the Group's medical device products, in Year 2015; and the increase in the Group's financing cost for the borrowings denominated in foreign exchange due to the depreciation of Renminbi during the second half of Year 2015.